Transposon mutagenesis identifies genes that transform neural stem cells into glioma-initiating cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 44, 2012, Pages

  Koso, Hideto ^a,b   Takeda, Haruna ^a,b   Yew, Christopher Chin Kuan ^a   Ward, Jerrold M ^a   Nariai, Naoki ^c   Ueno, Kazuko ^c   Nagasaki, Masao ^c   Watanabe, Sumiko ^b   Rust, Alistair G ^d   Adams, David J ^d   Copeland, Neal G ^a,e   Jenkins, Nancy A ^a,e  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^e HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; BRD4 PROTEIN; CRK PROTEIN; DLG1 PROTEIN; DMXL1 PROTEIN; FOCAL ADHESION KINASE 1; GAB1 PROTEIN; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NESTIN; NF1 PROTEIN; PAR6 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN KINASE B; PROTEIN P53; PROTEIN S 100; PSMD14 PROTEIN; PUM2 PROTEIN; RAC PROTEIN; SCATTER FACTOR RECEPTOR; SFI1 PROTEIN; SMARCC1 PROTEIN; STAG2 PROTEIN; SYNDECAN; TRANSCRIPTION FACTOR GLI3; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; USP3 PROTEIN; WASF2 PROTEIN; ZFP326 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; GENE INSERTION SEQUENCE; GLIOBLASTOMA; MACROGLIA; MUTAGENESIS; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSPOSON;

EID: 84868128332     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1215899109     Document Type: Article

References (55)

1. Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109(1):93-108.
2. Singh SK, et al. (2004) Identification of human brain tumour initiating cells. Nature 432(7015):396-401.
3. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414(6859):105-111.
4. Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216): 1061-1068.
5. Verhaak RG, et al.; Cancer Genome Atlas Research Network (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98-110.
6. Alcantara Llaguno S, et al. (2009) Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 15(1):45-56.
7. Marumoto T, et al. (2009) Development of a novel mouse glioma model using lentiviral vectors. Nat Med 15(1):110-116.
8. Kool J, Berns A (2009) High-throughput insertional mutagenesis screens in mice to identify oncogenic networks. Nat Rev Cancer 9(6):389-399.
9. Dupuy AJ, et al. (2009) A modified sleeping beauty transposon system that can be used to model a wide variety of human cancers in mice. Cancer Res 69(20):8150-8156.
10. Dupuy AJ, Akagi K, Largaespada DA, Copeland NG, Jenkins NA (2005) Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system. Nature 436(7048):221-226.
11. Tronche F, et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23(1):99-103.
12. Merkle FT, Alvarez-Buylla A (2006) Neural stem cells in mammalian development. Curr Opin Cell Biol 18(6):704-709.
13. Reynolds BA, Weiss S (1996) Clonal and population analyses demonstrate that an EGFresponsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175(1):1-13.
14. Collier LS, Carlson CM, Ravimohan S, Dupuy AJ, Largaespada DA (2005) Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse. Nature 436(7048):272-276.
15. Olive KP, et al. (2004) Mutant p53 gain of function in two mouse models of Li- Fraumeni syndrome. Cell 119(6):847-860.
16. Milner J, Medcalf EA (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65(5):765-774.
17. Shaulian E, Zauberman A, Ginsberg D, Oren M (1992) Identification of a minimal transforming domain of p53: Negative dominance through abrogation of sequencespecific DNA binding. Mol Cell Biol 12(12):5581-5592.
18. Liu G, et al. (2004) Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 36(1):63-68.
19. Cahoy JD, et al. (2008) A transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 28(1):264-278.
20. Stiles CD, Rowitch DH (2008) Glioma stem cells: A midterm exam. Neuron 58(6): 832-846.
21. Bachoo RM, et al. (2002) Epidermal growth factor receptor and Ink4a/Arf: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 1(3):269-277.
22. March HN, et al. (2011) Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nat Genet 43(12):1202-1209.
23. Doe CQ (2008) Neural stem cells: Balancing self-renewal with differentiation. Development 135(9):1575-1587.
24. Wang B, Fallon JF, Beachy PA (2000) Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100 (4):423-434.
25. Zhu Y, Parada LF (2001) Neurofibromin, a tumor suppressor in the nervous system. Exp Cell Res 264(1):19-28.
26. Parsons DW, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897):1807-1812.
27. Forbes S, et al. (2006) COSMIC 2005. Br J Cancer 94(2):318-322.
28. Ruf S, et al. (2011) Large-scale analysis of the regulatory architecture of the mouse genome with a transposon-associated sensor. Nat Genet 43(4):379-386.
29. Sawey ET, et al. (2011) Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by Oncogenomic screening. Cancer Cell 19(3):347-358.
30. Zender L, et al. (2008) An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135(5):852-864.
31. Merlo LM, Pepper JW, Reid BJ, Maley CC (2006) Cancer as an evolutionary and ecological process. Nat Rev Cancer 6(12):924-935.
32. Gerlinger M, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10):883-892.
33. Anderson K, et al. (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469(7330):356-361.
34. Du Y, Jenkins NA, Copeland NG (2005) Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood 106 (12):3932-3939.
35. Shing DC, et al. (2007) Overexpression of sPRDM16 coupled with loss of p53 induces myeloid leukemias in mice. J Clin Invest 117(12):3696-3707.
36. Goyama S, et al. (2008) Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 3(2):207-220.
37. Visvader JE (2011) Cells of origin in cancer. Nature 469(7330):314-322.
38. Liu C, et al. (2011) Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 146(2):209-221.
39. Laywell ED, Rakic P, Kukekov VG, Holland EC, Steindler DA (2000) Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain. Proc Natl Acad Sci USA 97(25):13883-13888.
40. Dannenberg JH, van Rossum A, Schuijff L, te Riele H (2000) Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev 14(23): 3051-3064.
41. Holland EC, Hively WP, Gallo V, Varmus HE (1998) Modeling mutations in the G1 arrest pathway in human gliomas: Overexpression of CDK4 but not loss of INK4a-ARF induces hyperploidy in cultured mouse astrocytes. Genes Dev 12(23):3644-3649.
42. Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA (2004) The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis. Oncogene 23(2):379-385.
43. Gregorian C, et al. (2009) Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis. J Neurosci 29(6):1874-1886.
44. Chow LM, et al. (2011) Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain. Cancer Cell 19(3):305-316.
45. Mann KM, et al.; Australian Pancreatic Cancer Genome Initiative (2012) Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. Proc Natl Acad Sci USA 109(16):5934-5941.
46. Wu X, et al. (2012) Clonal selection drives genetic divergence of metastatic medulloblastoma. Nature 482(7386):529-533.
47. Solomon DA, et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333(6045):1039-1043.
48. Xie P, Stunz LL, Larison KD, Yang B, Bishop GA (2007) Tumor necrosis factor receptorassociated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. Immunity 27(2):253-267.
49. Li M, et al. (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43(9):828-829.
50. Landgren H, Carlsson P (2004) FoxJ3, a novel mammalian forkhead gene expressed in neuroectoderm, neural crest, and myotome. Dev Dyn 231(2):396-401.
51. Menges CW, Altomare DA, Testa JR (2009) FAS-associated factor 1 (FAF1): Diverse functions and implications for oncogenesis. Cell Cycle 8(16):2528-2534.
52. Chen Y, et al. (2007) Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2(5):1044-1051.
53. Koudijs MJ, et al. (2011) High-throughput semiquantitative analysis of insertional mutations in heterogeneous tumors. Genome Res 21(12):2181-2189.
54. Munchhof AM, et al. (2006) Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells. Hum Mol Genet 15(11):1858-1869.
55. Chen Z, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436(7051):725-730.